Clarametyx Biosciences Strengthens Executive Leadership to Accelerate Clinical Development Efforts [Yahoo! Finance]
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
How The Reset Price Target Is Shaping The Emergent BioSolutions (EBS) Investment Story [Yahoo! Finance]
Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures
How The Investment Narrative For Emergent BioSolutions (EBS) Is Shifting After The $12 Target Reset [Yahoo! Finance]